The trademark application ADIPOCYNAR was filed by EVEAR Extraction, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on June 22, 2021, and it was registered by office on September 29, 2021 without any oppositions.
The application was filed in French (English was selected as the second language).